Covovax Expected To Hit Market In June

Pune: The Serum Institute of India (SII) is currently developing another vaccine with US drug-maker Novavax. Serum’s CEO Adar Poonawalla said on Saturday he hopes to launch the new vaccine ‘Covovax’ by June.

Covovax has been found to be 89.3 per cent effective in a UK trial.

“Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!” Poonawalla tweeted this afternoon.

Poonawalla’s firm is already making Covishield, developed in partnership with the Oxford University and British-Swedish firm AstraZeneca. Covishield and Bharat Biotech’s Covaxin are being used in the first phase of vaccination process in India.

Also Read: Serum Institute Of India Applies For Study Trial Of Novavax Vaccine

Get real time updates directly on you device, subscribe now.

Comments are closed.